Annual Operating Expenses
$259.43 M
+$181.45 M+232.72%
31 December 2023
Summary:
Catalyst Pharmaceuticals annual total operating expenses is currently $259.43 million, with the most recent change of +$181.45 million (+232.72%) on 31 December 2023. During the last 3 years, it has risen by +$198.69 million (+327.17%). CPRX annual operating expenses is now at all-time high.CPRX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$58.51 M
+$5.45 M+10.27%
30 September 2024
Summary:
Catalyst Pharmaceuticals quarterly total operating expenses is currently $58.51 million, with the most recent change of +$5.45 million (+10.27%) on 30 September 2024. Over the past year, it has dropped by -$67.20 million (-53.46%). CPRX quarterly operating expenses is now -53.46% below its all-time high of $125.71 million, reached on 30 September 2023.CPRX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +232.7% | -53.5% |
| 3 y3 years | +327.2% | +251.6% |
| 5 y5 years | +624.8% | +362.0% |
CPRX Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +327.2% | -53.5% | +251.6% |
| 5 y | 5 years | at high | +624.8% | -53.5% | +362.0% |
| alltime | all time | at high | >+9999.0% | -53.5% | >+9999.0% |
Catalyst Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $58.51 M(+10.3%) |
| June 2024 | - | $53.06 M(-9.9%) |
| Mar 2024 | - | $58.86 M(+10.9%) |
| Dec 2023 | $259.43 M(+232.7%) | $53.07 M(-57.8%) |
| Sept 2023 | - | $125.71 M(+207.8%) |
| June 2023 | - | $40.84 M(+2.6%) |
| Mar 2023 | - | $39.81 M(+112.2%) |
| Dec 2022 | $77.97 M(+17.1%) | $18.76 M(-16.5%) |
| Sept 2022 | - | $22.48 M(+33.0%) |
| June 2022 | - | $16.90 M(-14.8%) |
| Mar 2022 | - | $19.83 M(+8.9%) |
| Dec 2021 | $66.56 M(+9.6%) | $18.22 M(+9.5%) |
| Sept 2021 | - | $16.64 M(+4.1%) |
| June 2021 | - | $15.98 M(+1.6%) |
| Mar 2021 | - | $15.72 M(-10.3%) |
| Dec 2020 | $60.73 M(+9.0%) | $17.53 M(+27.6%) |
| Sept 2020 | - | $13.73 M(-9.5%) |
| June 2020 | - | $15.18 M(+6.3%) |
| Mar 2020 | - | $14.29 M(-19.4%) |
| Dec 2019 | $55.72 M(+55.7%) | $17.72 M(+39.9%) |
| Sept 2019 | - | $12.66 M(-7.0%) |
| June 2019 | - | $13.62 M(+16.1%) |
| Mar 2019 | - | $11.72 M(-23.6%) |
| Dec 2018 | $35.80 M(+91.6%) | $15.34 M(+87.5%) |
| Sept 2018 | - | $8.18 M(+29.1%) |
| June 2018 | - | $6.34 M(+6.8%) |
| Mar 2018 | - | $5.93 M(+7.6%) |
| Dec 2017 | $18.68 M(-3.1%) | $5.51 M(+28.0%) |
| Sept 2017 | - | $4.31 M(+3.0%) |
| June 2017 | - | $4.18 M(-10.7%) |
| Mar 2017 | - | $4.68 M(+8.5%) |
| Dec 2016 | $19.28 M(-5.5%) | $4.31 M(+10.2%) |
| Sept 2016 | - | $3.91 M(-18.7%) |
| June 2016 | - | $4.81 M(-22.8%) |
| Mar 2016 | - | $6.24 M(+0.7%) |
| Dec 2015 | $20.40 M | $6.19 M(+23.4%) |
| Sept 2015 | - | $5.02 M(+2.5%) |
| June 2015 | - | $4.90 M(+14.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $4.29 M(+7.7%) |
| Dec 2014 | $14.59 M(+41.5%) | $3.98 M(-3.0%) |
| Sept 2014 | - | $4.11 M(+37.4%) |
| June 2014 | - | $2.99 M(-14.8%) |
| Mar 2014 | - | $3.51 M(+29.6%) |
| Dec 2013 | $10.31 M(+97.5%) | $2.71 M(-16.6%) |
| Sept 2013 | - | $3.25 M(+22.3%) |
| June 2013 | - | $2.65 M(+55.6%) |
| Mar 2013 | - | $1.71 M(+13.3%) |
| Dec 2012 | $5.22 M(-14.2%) | $1.51 M(+17.3%) |
| Sept 2012 | - | $1.28 M(+20.3%) |
| June 2012 | - | $1.07 M(-21.8%) |
| Mar 2012 | - | $1.36 M(-32.9%) |
| Dec 2011 | $6.08 M(+34.8%) | $2.03 M(+79.9%) |
| Sept 2011 | - | $1.13 M(-19.1%) |
| June 2011 | - | $1.40 M(-8.0%) |
| Mar 2011 | - | $1.52 M(+24.4%) |
| Dec 2010 | $4.51 M(-38.0%) | $1.22 M(+34.4%) |
| Sept 2010 | - | $908.50 K(-31.9%) |
| June 2010 | - | $1.33 M(+26.9%) |
| Mar 2010 | - | $1.05 M(-10.2%) |
| Dec 2009 | $7.28 M(-33.2%) | $1.17 M(-9.5%) |
| Sept 2009 | - | $1.29 M(-26.9%) |
| June 2009 | - | $1.77 M(-41.9%) |
| Mar 2009 | - | $3.04 M(-19.7%) |
| Dec 2008 | $10.89 M(+116.7%) | $3.79 M(+30.1%) |
| Sept 2008 | - | $2.91 M(+18.3%) |
| June 2008 | - | $2.46 M(+42.9%) |
| Mar 2008 | - | $1.72 M(+50.9%) |
| Dec 2007 | $5.03 M(+73.2%) | $1.14 M(+20.2%) |
| Sept 2007 | - | $950.40 K(-33.9%) |
| June 2007 | - | $1.44 M(-4.0%) |
| Mar 2007 | - | $1.50 M(+69.1%) |
| Dec 2006 | $2.90 M(+59.3%) | $885.20 K(-34.0%) |
| Sept 2006 | - | $1.34 M(+276.0%) |
| June 2006 | - | $357.00 K |
| Dec 2005 | $1.82 M(+235.6%) | - |
| Dec 2004 | $543.00 K(+112.2%) | - |
| Dec 2002 | $255.90 K | - |
FAQ
- What is Catalyst Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual operating expenses year-on-year change?
- What is Catalyst Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly operating expenses year-on-year change?
What is Catalyst Pharmaceuticals annual total operating expenses?
The current annual operating expenses of CPRX is $259.43 M
What is the all time high annual operating expenses for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual total operating expenses is $259.43 M
What is Catalyst Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, CPRX annual total operating expenses has changed by +$181.45 M (+232.72%)
What is Catalyst Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of CPRX is $58.51 M
What is the all time high quarterly operating expenses for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly total operating expenses is $125.71 M
What is Catalyst Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, CPRX quarterly total operating expenses has changed by -$67.20 M (-53.46%)